Issues related to treatment challenges for cardiovascular disease. S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022; H.R. 7667 - Food and Drug Amendments of 2022; Consolidated Appropriations Act, 2023 (PL 117-328), Division FF, Title III - Food and Drug Administration, Subtitle B - Drugs and Biologics and Subtitle F, Chapter 1 - Clinical Trial Diversity and Modernization. Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); Issues related to capping out-of-pocket costs; Issues related to payments for ESRD services under Medicare; Issues related to Medicare Part D drug rebates; S. 1943 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021.
BUD - Budget/Appropriations HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
JONATHON JONES MATTHEW LEFFINGWELL JOHN MICHAEL GONZALEZ JONATHON JONES COREY MALMGREN JONATHON JONES JOHN MICHAEL GONZALEZ COREY MALMGREN